Board member Stuart Diamond to depart after 2025 annual meeting; no disagreement cited

bioAffinity Technologies, Inc.

Stuart Diamond notified the board on April 12, 2025, of his decision not to stand for re-election.
Diamond will continue to serve as a director until the 2025 annual meeting.
His departure is not due to any disagreement with the company's operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stuart Diamond

Director

BIAF · bioAffinity Technologies, Inc.

Filed: April 14, 2025, 7:59 PM ET

On April 12, 2025, Stuart Diamond, a member of the board of directors (the “Board”) of bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), notified the Company of his decision not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stuart Diamond departed as Director at bioAffinity Technologies, Inc..

Action: not stand for re-election
Role: Director

Exact text from the filing

On April 12, 2025, Stuart Diamond, a member of the board of directors (the “Board”) of bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), notified the Company of his decision not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).

View on SEC.gov

bioAffinity Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-004562

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.